Prostate cancer screening and management in patients candidate for endoscopic enucleation of the prostate: an international survey.

Autor: Uleri A; Department of Urology, APHM, North Academic Hospital, Marseille, France. alessandrouleri@outlook.it., Cornu JN; Department of Urology, Charles-Nicolle Hospital, University of Rouen Normandy, Rouen, France., Pradere B; Department of Urology, La Croix du Sud Hôpital, Quint Fonsegrives, France., Herrmann TRW; Department of Urology, Cantonal Hospital Thurgau AG, Fraunfeld, Switzerland.; Hannover Medical School, Hannover, Germany.; Division of Urology, Department of Surgical Sciences, Stellenbosch University, Western Cape, South Africa., Misrai V; Department of Urology, Clinique Pasteur, Toulouse, France., Roupret M; Sorbonne University, GRC 5 Predictive Onco-Uro, AP-HP, Urology, Pitie-Salpetriere Hospital, Paris, France., De Nunzio C; Department of Urology, Sapienza University of Rome, Rome, Italy., Hashim H; Bristol Urological Institute, Southmead Hospital, Bristol, UK., Ploussard G; Department of Urology, La Croix du Sud Hôpital, Quint Fonsegrives, France., Baboudjian M; Department of Urology, APHM, North Academic Hospital, Marseille, France.
Jazyk: angličtina
Zdroj: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Oct 21. Date of Electronic Publication: 2024 Oct 21.
DOI: 10.1038/s41391-024-00909-w
Abstrakt: Background: To explore how urologists manage prostate cancer (PCa) screening and treatment in patients undergoing endoscopic enucleation of the prostate (EEP).
Methods: A team of experts in EEP collaboratively formulated the survey questions through an interactive process. The survey opened in January 2024 and closed in February 2024.
Results: 102 urologists responded, revealing that most use PSA and digital rectal examination for screening, with high PSA and abnormal DRE prompting prostate MRI. 75% perform pre-EEP biopsies. For incidental low-grade PCa, active surveillance is preferred. For intermediate-grade PCa, most use PSA and MRI for workup, often choosing active surveillance if post-EEP biopsies are negative. There's no consensus on abnormal post-operative PSA thresholds.
Conclusions: While urologists are aware of PCa management in EEP candidates, future work should focus on developing optimal post-EEP screening protocols.
(© 2024. The Author(s), under exclusive licence to Springer Nature Limited.)
Databáze: MEDLINE
Externí odkaz: